HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Masanori Noguchi Selected Research
Masanori Noguchi Research Topics
Disease
56
Neoplasms (Cancer)
05/2020 - 07/2003
54
Prostatic Neoplasms (Prostate Cancer)
01/2021 - 09/2002
6
Renal Cell Carcinoma (Grawitz Tumor)
08/2015 - 03/2007
4
Disease Progression
01/2021 - 08/2003
4
Carcinoma (Carcinomatosis)
12/2017 - 12/2006
4
Melanoma (Melanoma, Malignant)
04/2015 - 07/2003
4
Neoplasm Metastasis (Metastasis)
02/2005 - 05/2003
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 05/2012
2
Pancreatic Neoplasms (Pancreatic Cancer)
09/2013 - 09/2010
2
Kidney Neoplasms (Kidney Cancer)
06/2011 - 02/2009
1
Urologic Neoplasms (Urological Cancer)
09/2018
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2017
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1
Neuroblastoma
04/2015
1
Hepatocellular Carcinoma (Hepatoma)
01/2015
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2013
1
Stomach Neoplasms (Stomach Cancer)
01/2011
1
Injection Site Reaction
01/2011
1
Cellulitis
01/2011
1
Colitis
01/2011
1
Hemorrhage
01/2011
1
Lymphoma (Lymphomas)
12/2009
1
Mental Disorders (Mental Disorder)
11/2009
1
Bipolar Disorder (Manic Depressive Psychosis)
11/2009
1
Lower Urinary Tract Symptoms
09/2008
Drug/Important Bio-Agent (IBA)
69
Peptides (Polypeptides)
IBA
01/2021 - 05/2003
24
Antigens
IBA
05/2020 - 07/2003
20
Protein Subunit Vaccines
IBA
12/2017 - 10/2005
18
Cancer Vaccines
IBA
05/2020 - 12/2006
15
Immunoglobulin G (IgG)
IBA
11/2015 - 07/2003
13
HLA Antigens (Human Leukocyte Antigens)
IBA
09/2018 - 01/2004
12
Vaccines
IBA
01/2016 - 07/2003
10
HLA-A2 Antigen (HLA A2 Antigen)
IBA
11/2015 - 07/2003
10
HLA-A24 Antigen
IBA
09/2010 - 07/2003
8
Epitopes
IBA
11/2015 - 08/2003
7
Prostate-Specific Antigen (Semenogelase)
IBA
09/2018 - 05/2003
7
Hormones (Hormone)
IBA
12/2008 - 09/2003
6
Estramustine
FDA Link
04/2011 - 02/2004
6
HLA-A3 Antigen (HLA A3 Antigen)
IBA
09/2010 - 10/2005
5
Biomarkers (Surrogate Marker)
IBA
01/2020 - 02/2004
5
Phosphates (Orthophosphate)
IBA
04/2011 - 02/2004
4
Docetaxel (Taxotere)
FDA Link
01/2021 - 06/2012
3
HLA-A*26 antigen
IBA
10/2015 - 11/2009
3
Proteins (Proteins, Gene)
FDA Link
08/2015 - 07/2005
3
HLA-A Antigens (HLA-A)
IBA
01/2011 - 02/2009
3
HLA-A31 antigen
IBA
02/2009 - 10/2005
3
HLA-A11 Antigen
IBA
02/2009 - 10/2005
3
HLA-A*33 antigen
IBA
02/2009 - 10/2005
3
Polycomb-Group Proteins
IBA
11/2007 - 09/2004
2
Dexamethasone (Maxidex)
FDA Link
Generic
05/2020 - 12/2008
2
prostatic acid phosphatase
IBA
09/2018 - 09/2004
2
Platinum
IBA
12/2017 - 01/2016
2
Immune Checkpoint Inhibitors
IBA
01/2017 - 05/2013
2
Suspensions
IBA
09/2008 - 01/2004
2
Enhancer of Zeste Homolog 2 Protein
IBA
11/2007 - 09/2004
2
Androgen Receptors (Androgen Receptor)
IBA
08/2007 - 11/2006
2
Messenger RNA (mRNA)
IBA
03/2007 - 12/2006
1
Plant Extracts
IBA
12/2017
1
keishibukuryogan
IBA
12/2017
1
bu-zhong-yi-qi-tang
IBA
12/2017
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2016
1
Haptoglobins
IBA
12/2015
1
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) (p56 lck)
IBA
11/2015
1
src-Family Kinases
IBA
11/2015
1
Monoclonal Antibodies
IBA
08/2015
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
08/2015
1
trioctyl phosphine oxide (TOPO)
IBA
08/2015
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
08/2015
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
04/2015
1
EphB6 Receptor
IBA
04/2015
1
Erythropoietin
FDA Link
04/2015
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2015
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
04/2015
1
Therapeutic Uses
IBA
05/2013
1
Aldehyde Dehydrogenase 1 Family
IBA
01/2013
1
Vinblastine (Vinblastine Sulfate)
FDA Link
09/2011
1
Cisplatin (Platino)
FDA Link
Generic
09/2011
1
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2011
1
Methotrexate (Mexate)
FDA Link
Generic
09/2011
1
Sunitinib (Sutent)
FDA Link
01/2011
1
Gemcitabine
FDA Link
09/2010
1
Tubulin
IBA
09/2010
1
DNA (Deoxyribonucleic Acid)
IBA
11/2009
1
HLA-A*02:01 antigen
IBA
11/2009
1
HLA-A*26:01 antigen
IBA
11/2009
1
HLA-A*26:03 antigen
IBA
11/2009
1
Papillomavirus Vaccines (HPV Vaccines)
IBA
02/2009
1
vitespin
IBA
02/2009
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
02/2009
1
Glucocorticoids
IBA
12/2008
1
Ethanol (Ethyl Alcohol)
IBA
09/2008
1
HLA-G Antigens (HLA G)
IBA
12/2007
1
Cytokines
IBA
12/2007
Therapy/Procedure
20
Immunotherapy
01/2017 - 07/2003
17
Castration
05/2020 - 07/2010
11
Prostatectomy (Retropubic Prostatectomy)
04/2015 - 09/2002
11
Therapeutics
09/2011 - 09/2002
8
Drug Therapy (Chemotherapy)
12/2017 - 02/2009
1
Aftercare (After-Treatment)
06/2012
1
Radiotherapy
12/2009